MYCONYS

This brand name is authorized in Nigeria.

Active ingredients

The drug MYCONYS contains one active pharmaceutical ingredient (API):

1
UNII BDF1O1C72E - NYSTATIN
 

Nystatin is an antifungal antibiotic active against a wide range of yeasts and yeast-like fungi, including Candida albicans.

 
Read more about Nystatin

Packages

This drug has been approved in Nigeria as follows:

Identifier Form Presentation Description Approval
A11-0671 Suspension MYCONYS ORAL SUSPENSION SUSP 100,000 IU MYCONYS ORAL SUSPENSION NYSTATIN NYSTATIN 100,000 IU GLYCERINE PROPYLENE GLYCOL MAGNESIUM ALUMINIUM SILICATE METHYL PARABEN A11-0671 Drugs ANTIINFECTIVES FOR SYSTEMIC USE Nigerian Products 30ml POM 1 19/05/2023 JAWA INTERNATIONAL LIMITED, Plot 6, Abimbola Way, Isolo Industrial Estate 8036887062 spjawasil@gmail.com JAWA INTERNATIONAL LIMITED, JAWA HOUSE, PLOT 6 ABIMBOLA WAY,ISOLO INDUSTRIAL ESTATE,ISOLO,LAGOS., JAWA INTERNATIONAL LIMITED, JAWA HOUSE, PLOT 6 ABIMBOLA WAY,ISOLO INDUSTRIAL ESTATE,ISOLO,LAGOS., Nigeria 30/11/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
A07AA02 Nystatin A Alimentary tract and metabolism → A07 Antidiarrheals, intestinal antiinflammatory/antiinfective agents → A07A Intestinal antiinfectives → A07AA Antibiotics
Discover more medicines within A07AA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
NG Registered Drug Product Database A11-0671

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.